© Copyright 2025 American Medical Association. All rights reserved.
Radiopharmaceutical localization of inflammatory processes using CPT® Code 78807 involves the application of single photon emission computed tomography (SPECT) in conjunction with a radiolabeled isotope tracer. This advanced imaging technique is specifically designed to identify and localize areas of inflammation within the body. The radiolabeled isotope tracer is engineered to bind selectively to inflammatory cells, allowing for precise targeting of regions affected by inflammation or infection, whether acute or chronic. The procedure begins with the establishment of an intravenous line through which the radiolabeled tracer is administered directly into the patient's circulatory system. Alternatively, a blood sample may be drawn, and the white blood cells are separated via centrifugation, tagged with the isotope tracer, and subsequently reintroduced into the patient. Once the tracer is in circulation, it migrates to sites of inflammation, enabling visualization. During the imaging process, the patient is positioned on an imaging table while one or more gamma cameras rotate around the body, capturing a three-dimensional view of the targeted area. The emitted radioactive energy is then converted into detailed images, which are processed and displayed in tomographic sections or as a cinematic sequence. The physician interprets these images and compiles a comprehensive written report detailing the findings of the study, which is crucial for further clinical decision-making.
© Copyright 2025 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 78807 is indicated for the localization of inflammatory processes within the body. This imaging technique is particularly useful in the following scenarios:
The procedure for CPT® Code 78807 involves several key steps that ensure accurate localization of inflammatory processes:
After the completion of the procedure associated with CPT® Code 78807, patients may be monitored for any immediate reactions to the radiolabeled tracer. There are typically no specific post-procedure care requirements, but patients may be advised to drink plenty of fluids to help flush the tracer from their system. The physician will review the findings from the imaging study and discuss the results with the patient, which may influence further diagnostic or therapeutic decisions. Follow-up appointments may be scheduled to assess the patient's condition based on the findings of the imaging study.
| Short Descr | NUCLEAR LOCALIZATION/ABSCESS | Medium Descr | RP LOCLZJ INFLAMMATORY PROCESS TOMOG SPECT | Long Descr | Radiopharmaceutical localization of inflammatory process; tomographic (SPECT) | Status Code | Active Code | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 1 - Diagnostic Tests for Radiology Services | Multiple Procedures (51) | 2 - Standard payment adjustment rules for multiple procedures apply. | Bilateral Surgery (50) | 0 - 150% payment adjustment for bilateral procedures does NOT apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 0 - Payment restriction for assistants at surgery applies to this procedure... | Co-Surgeons (62) | 0 - Co-surgeons not permitted for this procedure. | Team Surgery (66) | 0 - Team surgeons not permitted for this procedure. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | APC Status Indicator | Procedure or Service, Not Discounted when Multiple | Type of Service (TOS) | 4 - Diagnostic Radiology | Berenson-Eggers TOS (BETOS) | I1E - Standard imaging - nuclear medicine | MUE | Not applicable/unspecified. | CCS Clinical Classification | 209 - Radioisotope scan and function studies |
Get instant expert-level medical coding assistance.